Researchers



Results 141-160 of 404
Issue DateTitleAuthor(s)TypeМp-cat.
2020Chemometrically Assisted RP-HPLC Method Development for Efficient Separation of Ivabradine and its Eleven ImpuritiesTomić, Jovana; Ivković, Branka  ; Oljačić, Slavica  ; Nikolić, Katarina  ; Maljurić, Nevena  ; Protić, Ana  ; Agbaba, Danica Article
23M23
2020Combined ligand-based and structure-based approaches in rational drug design of novel 5-HT2A receptor antagonistsRadan, Milica M.  ; Ružić, Dušan B.  ; Mirjana Antonijevic; Teodora Djikic; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2019The SF5 moiety as promising substituent for the design of novel D2 and D3 receptors ligandsElek, Milica; Frank, Annika; Đoković, Nemanja  ; Oljačić, Slavica  ; Živković, Aleksandra; Nikolić, Katarina  ; Stark, HolgerConference Paper
Mp. category will be shown later
2019Severe hepatotoxicity induced by efavirenz in a treatment-naïve, low body mass index HIV-infected, female patient with no hepatitis and other virus co-infectionsDragović-Lukić, Gordana  ; Nikolić, Katarina  ; Dimitrijević, Božana  ; Jevtović, Đorđe ; Salemović, Dubravka; Tomanović, Nada  ; Boričić, Ivan  Article
23M23
2019Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening ApproachesVucicevic, Jelica; Nikolić, Katarina  ; Mitchell, John B.O.Article
21M21
2019Is there a borderline between cytotoxic and antimetastatic effects of selective Histone deacetylase 6 inhibitors in solid malignancies?Nikolić, Katarina M.  ; Ružić, Dušan B.  ; Milan Beljkas  ; Petković, Miloš R.  ; Sheraz Gul; Juan F. Santibanez; Srdić-Rajić, Tatjana V.  Conference Paper
Mp. category will be shown later
2019Structure and ligand based drug design strategies in the development of novel serotonin 5-HT2A receptor antagonistsRadan, Milica M.  ; Mirjana Antonijevic; Ružić, Dušan B.  ; Đikić, Teodora M. ; Danica Agbaba; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2019Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase-6 InhibitorsRužić, Dušan  ; Petković, Miloš  ; Agbaba, Danica ; Ganesan, A.; Nikolić, Katarina  Article
21M21
2019Development and Screening of Novel Chemical Probes Targeting Histone MethyltransferaseSi, Yang; Bon, Corentin; Ružić, Dušan  ; Nikolić, Katarina  ; Agou, Fabrice; Halby, Ludovic; Arimondo, PaolaConference Paper
Mp. category will be shown later
2019Structure-Based Design of Selective Histone Deacetylase 6 Zinc Binding GroupsAlves, Avelar Leandro A.; Ružić, Dušan  ; Đoković, Nemanja  ; Kurz, Thomas; Nikolić, Katarina  Article
21M21
2019Combined 3D-QSAR modeling, molecular dynamics and molecular docking studies in rational drug design of novel 5-HT2A antagonistsRadan, Milica M.  ; Mirjana Antonijevic; Đikić, Teodora M. ; Ružić, Dušan B.  ; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2019Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-TargetsStevanović, Strahinja; Senćanski, Milan  ; Danel, Mathieu; Menendez, Christophe; Belguedj, Roumaissa; Bouraiou, Abdelmalek; Nikolić, Katarina M.  ; Cojean, Sandrine; Loiseau, Philippe Marie; Glišić, Sanja  ;
Baltas, Michel; García-Sosa, Alfonso;
Article
21M21
2019Rational design of multi-target compounds with potential anticancer activityDobričić, Vladimir D.  ; Olujić, Jelena; Nikolić, Katarina  ; Vučićević, Jelica; Gagić, Žarko ; Filipić, Slavica  ; Agbaba, Danica ; Čudina, Olivera  Conference Paper
Mp. category will be shown later
2019Pentafluorosulfanyl (SF5) moiety as promising substituent in synthesis and design of novel D2 and D3 receptors ligandsMilica Elek; Annika Frank; Đoković, Nemanja B.  ; Slavica Oljacic; Aleksandra Zivkovic; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
20193D-QSAR studies and design of selective PI3K-α kinase inhibitors as potential antineoplasticsM. Jovanovic  ; Z. Gagic; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2019Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and ModelingBouchet, Samuel; Linot, Camille; Ružić, Dušan  ; Agbaba, Danica ; Fouchaq, Benoit; Roche, Joelle; Nikolić, Katarina  ; Blanquart, Christophe; Bertrand, PhilippeArticle
21M21
2019Preclinical data on (2-imidazolin-4-yl) phosphonatesNikolić, Katarina M.  ; Radan, Milica M.  ; Đikić, Teodora M. ; S. Rodríguez-Arévalo; A. Bagán; P. Pérez-Lozano; F. Vasilopoulou; C. Griñán-Ferré; M. Pallàs; B. Pérez;
L. F. Callado; E. Hernández; J. M. García-Fuster; J. A. García-Sevilla; J. Brea; M. I. Loza; L. Naesens; C. Escolano;
Conference Paper
Mp. category will be shown later
2019Structure and ligand based drug design strategies in the development of novel serotonin 5-HTt2a receptor antagonistsRadan, Milica  ; Antonijević, Mirjana; Ružić, Dušan  ; Đikić, Teodora ; Agbaba, Danica ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2019Rational drug design of novel 5-HT2A antagonistsRadan, Milica M.  ; Đikić, Teodora M. ; Ružić, Dušan B.  ; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2019Development and Screening of Novel Chemical Probes Targeting Histone MethyltransferasesYang Si; Corentin Bon; Ružić, Dušan B.  ; Nikolić, Katarina M.  ; Fabrice Agou; Ludovic Halby; Paola ArimondoConference Paper
Mp. category will be shown later